ITI Pharma and Healthcare Fund - Regular Plan - IDCW Reinvestment vs Tata India Pharma and Healthcare Fund Regular Plan Growth
NAV, returns and costs — not a recommendation.
 ITI Pharma and Healthcare Fund - Regular Plan - IDCW Reinvestment |  Tata India Pharma and Healthcare Fund Regular Plan Growth | |
|---|---|---|
| NAV | ₹17.6626 | ₹32.3705 |
| NAV date | 2026-09-30 | 2026-09-30 |
| 1 year | +11.85% | +7.91% |
| 3 year (p.a.) | +16.84% | +17.09% |
| 5 year (p.a.) | +12.35% | +12.49% |
| Expense ratio | 2.38% | 1.84% |
| Fund size | ₹237.99 Cr | ₹1386.99 Cr |
| Risk | — | — |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.